Oncology Central

HER2 testing and its predictive utility in anti-HER2 breast cancer therapy


Breast cancer treatment is dependent on accurate pathologic diagnosis. HER2 testing is now universally recommended as part of evaluation of invasive breast cancer. HER2 testing is available via various slide and non-slide based assays, and interpretation of results continues to evolve.

To view restricted content, please:

Leave A Comment